Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.
GHTC has named Jamie Bay Nishi as its new director. Currently, Ms. Nishi serves as Managing Director of Devex LIVE at Devex, a media platform for the global development community. She will assume the GHTC director position in late February.
GenomeWeb reports on GHTC's call to World Health Organization to establish an essential diagnostics list, quoting GHTC policy officer Matt Robinson.
As all eyes look toward President-elect Donald Trump's inauguration, GHTC examines the policy issues we'll be tracking on in 2017.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.